Simon Jones
Professor,
St. Mary's Hospital
Prof Simon Jones, Manchester (United Kingdom)
Simon Jones is a consultant in paediatric inherited metabolic diseases at the Willink Unit in Genomic Medicine, St. Mary's Hospital in Manchester, UK.
His major research interest is therapies for lysosomal storage diseases (LSDs).
He received his medical training at the Edinburgh University Medical School, Edinburgh, UK, with a BSc in Neurosciences. He moved to London and trained in Paediatrics at Guy's and St. Thomas' Hospital, London, UK. He has been working at the Willink Biochemical Genetics Unit in Manchester, UK since September 2005. Since 2008, he has been a consultant in paediatric inherited metabolic diseases at the Willink Unit and is now the clinical lead for the LSD service. The Willink Unit is now part of the Manchester Centre for Genomic Medicine at St. Mary's Hospital, Manchester, UK. He is also the medical director of the NIHR Manchester children's clinical research facility and an honorary MAHSC Professor in paediatrics and translational medicine.
Prof. Jones has been actively involved in many phase I-IV international multicentre trials of novel therapies for LSDs. He is currently the principal investigator in a number of LSD trials, including several first in human gene therapy trials. He is the author of over 150 peer-reviewed papers and 5 book chapters.
Simon Jones is a consultant in paediatric inherited metabolic diseases at the Willink Unit in Genomic Medicine, St. Mary's Hospital in Manchester, UK.
His major research interest is therapies for lysosomal storage diseases (LSDs).
He received his medical training at the Edinburgh University Medical School, Edinburgh, UK, with a BSc in Neurosciences. He moved to London and trained in Paediatrics at Guy's and St. Thomas' Hospital, London, UK. He has been working at the Willink Biochemical Genetics Unit in Manchester, UK since September 2005. Since 2008, he has been a consultant in paediatric inherited metabolic diseases at the Willink Unit and is now the clinical lead for the LSD service. The Willink Unit is now part of the Manchester Centre for Genomic Medicine at St. Mary's Hospital, Manchester, UK. He is also the medical director of the NIHR Manchester children's clinical research facility and an honorary MAHSC Professor in paediatrics and translational medicine.
Prof. Jones has been actively involved in many phase I-IV international multicentre trials of novel therapies for LSDs. He is currently the principal investigator in a number of LSD trials, including several first in human gene therapy trials. He is the author of over 150 peer-reviewed papers and 5 book chapters.
)
)
){kind=logo}
){kind=logo}
){kind=logo}